Financials
| Trading Statement | Apr. 24, 2025 |
| Annual Financial Report and Notice of AGM | Mar. 19, 2025 |
| 2024 Annual Report and Accounts | Mar. 19, 2025 |
| Final Results | Feb. 26, 2025 |
| Trading Statement | Nov. 07, 2024 |
| Half-year Report | Aug. 08, 2024 |
| Trading Statement | Apr. 25, 2024 |
Proxies
| Result of AGM | Apr. 24, 2025 |
| Notice of 2025 Annual General Meeting | Mar. 19, 2025 |
| 2024 Annual General Meeting Update Statement | Oct. 24, 2024 |
| Result of AGM | Apr. 25, 2024 |
| Result of AGM | Apr. 28, 2023 |
| Annual General Meeting Notice of Meeting | Mar. 16, 2023 |
| Result of AGM | Apr. 25, 2022 |
Ownership Update
| Director/PDMR Shareholding | Jun. 09, 2025 |
| Director/PDMR Shareholding | Jun. 05, 2025 |
| Director/PDMR Shareholding | Jun. 03, 2025 |
| Director/PDMR Shareholding | May. 20, 2025 |
| Director/PDMR Shareholding | May. 08, 2025 |
| Director/PDMR Shareholding | Apr. 30, 2025 |
| Director/PDMR Shareholding | Apr. 10, 2025 |
Announcements
| Fitch upgrades Hikma to ‘BBB’ | May. 29, 2025 |
| S&P upgrades Hikma to ‘BBB’ | May. 08, 2025 |
| Settlement agreement for Xyrem® US lawsuits | May. 08, 2025 |
| Special Business passed at AGM | Apr. 24, 2025 |
| Block listing Interim Review | Apr. 01, 2025 |
| Notice of Results | Feb. 10, 2025 |
| Outcome of Audit Tender Process | Nov. 07, 2024 |
Prospectuses
| Circular and Prospectus for Roxane Acquisition EGM | Jan. 22, 2016 |
| IPO Prospectus | Nov. 01, 2005 |